Delix Therapeutics
0 followers
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles.... Read more
Org chart
Mark Rus
CEO
Mark Rus
Collapse
David Olson
CIO, Head of SAB, Co-Founder
Kurt Rasmussen
Chief Scientific Officer
Tricia Mccall
Chief People Officer
Matt Gorman
CFO
Eliseo Salinas
Head of Research & Development
Retsina Meyer
Head of Corporate Strategy
Sharon Engel
Senior Director of Pharmacology
Milan Chytil
Director of Medicinal Chemistry
